Treasury Chief Reeves Intends Targeted Measures on Household Expenses in Forthcoming Budget
Treasury head Reeves has announced she is preparing "specific measures to tackle cost of living pressures" in the upcoming financial statement.
In comments to the BBC, she stated that reducing price rises is a collective task of both the administration and the central bank.
The United Kingdom's price growth is expected to be the highest among the Group of Seven advanced economies this calendar year and next.
Potential Utility Cost Measures
It is understood the government could intervene to bring down utility costs, for instance by reducing the current 5% rate of value-added tax charged on energy supplies.
An additional approach is to lower some of the regulatory levies presently included in bills.
Budgetary Limitations and Expert Expectations
The administration will receive the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will show how much space there is for these actions.
The consensus from the majority of analysts is that Reeves will have to declare higher taxes or budget cuts in order to meet her self-imposed borrowing rules.
Previously on Thursday, estimates indicated there was a twenty-two billion pound gap for the Treasury chief to fill, which is at the more modest range of forecasts.
"It is a joint responsibility between the Bank of England and the administration to continue tackling some of the sources of inflation," Reeves stated to the BBC in Washington, at the conferences of the International Monetary Fund and global financial institution.
Tax Commitments and Global Concerns
While a great deal of the focus has been on likely tax rises, the chancellor said the latest data from the fiscal watchdog had not altered her commitment to manifesto promises not to increase rates on earnings tax, VAT or National Insurance.
She blamed an "unpredictable global environment" with growing geopolitical and commercial concerns for the fiscal revenue measures, likely to be focused on those "wealthiest."
International Economic Disputes
Addressing concerns about the United Kingdom's commercial links with China she said: "The UK's security interests invariably come first."
Recent statement by Chinese authorities to increase trade restrictions on critical minerals and other materials that are key for advanced tech production led American leader Donald Trump to propose an further 100% tariff on goods from China, increasing the possibility of an all-out trade war between the two global powers.
The US Treasury Secretary described the Chinese action "economic coercion" and "a global supply chain control attempt."
Inquired about accepting the American proposal to participate in its battle with China, Reeves said she was "extremely troubled" by Chinese actions and called on the Beijing authorities "not to put up barriers and limit trade."
She said the decision was "damaging for the world economy and creates additional headwinds."
"In my view there are areas where we need to confront China, but there are also significant opportunities to sell into Chinese markets, including financial services and other areas of the economy. We've got to achieve that balance right."
The chancellor also stated she was cooperating with other major economies "regarding our own critical minerals approach, so that we are reduced dependence."
Health Service Medicine Pricing and Funding
Reeves also acknowledged that the cost the NHS spends on medicines could rise as a consequence of current discussions with the US government and its drugs companies, in return for reduced taxes and investment.
A number of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or scrapping operations in the United Kingdom, with several attributing the modest returns they are receiving.
Last month, the government science advisor said the price the NHS pays for drugs would must go up to stop businesses and pharmaceutical investment departing from the UK.
The Chancellor told media: "It has been observed due to the cost structure, that drug testing, new drugs have not been offered in the United Kingdom in the way that they are in other EU nations."
"Our aim is to make sure that patients receiving treatment from the NHS are able to access the finest essential drugs in the globe. And so we are looking at all of that, and... aiming to secure additional investment into Britain."